Don’t Trade in the Dark—Get Your Pre-Market Report Every Day.Join Now
Run a search on a company

ERIS Lifesciences Ltd

Pharmaceuticals & Biotechnology | Small Cap

ERIS Lifesciences Ltd Health Insights
Health Score : 7.15Health Score : 7.15

ERIS Lifesciences shows a mixed financial performance. The company excels in solvency and profitability, indicating financial stability and efficient use of resources. Growth and financial ratios are also strong, driven by significant revenue and operating profit increases. However, liquidity and efficiency ratios are areas of concern. While the company is managing its debts well and achieving high profits, it needs to improve its ability to meet short-term obligations and optimize asset turnover. Overall, ERIS Lifesciences demonstrates solid financial health with potential for improvement in specific operational areas. The healthcare industry's dynamics, including regulatory changes and market competition, could influence future performance.

Latest Report

View All
Q3 FY26 Earnings Conference Call

Latest News

View All

The Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.

Overview
Ratio
Financial
ERIS Lifesciences Ltd Health Insights
Health Score : 7.15Health Score : 7.15

ERIS Lifesciences shows a mixed financial performance. The company excels in solvency and profitability, indicating financial stability and efficient use of resources. Growth and financial ratios are also strong, driven by significant revenue and operating profit increases. However, liquidity and efficiency ratios are areas of concern. While the company is managing its debts well and achieving high profits, it needs to improve its ability to meet short-term obligations and optimize asset turnover. Overall, ERIS Lifesciences demonstrates solid financial health with potential for improvement in specific operational areas. The healthcare industry's dynamics, including regulatory changes and market competition, could influence future performance.

Latest Report

View All
Q3 FY26 Earnings Conference Call

Latest News

View All

The Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.

Neutral

Overall Valuation Score

Highly Undervalued
Undervalued
Neutral
Overvalued
Highly Overvalued
Neutral

P/E RATIO (TTM)

82.25

Neutral

Industry Median

28.62

Neutral
Neutral

Small Cap Median

27.17

Neutral

P/E RATIO

32.39

P/B RATIO

5.14

Highly Overvalued

Industry Median

3.17

Highly Overvalued
Highly Overvalued

Small Cap Median

2.62

Highly Overvalued

P/S RATIO

6.24

Highly Overvalued

Industry Median

3.42

Highly Overvalued
Highly Overvalued

Small Cap Median

2.55

Highly Overvalued

Others

Neutral

PEG RATIO

0.00

Neutral
Overvalued

EV/EBITDA RATIO

18.39

Overvalued

The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹1448.4 as on Jun 21, 2026.

Markets Depth NSE

Buy Orders

  1. Bid

    Quantity

    Orders

  2. No buy depth

  3. Total

    0

    0

Sell Orders

  1. Ask

    Quantity

    Orders

  2. No sell depth

  3. Total

    0

    0

BidsOffers
50.00%50.00%

Markets Today NSE

  1. High

    0.00

  2. Low

    0.00

  3. Open

    0.00

  4. Close

    0.00

  5. Prev Close

    0.00

  6. Avg Price

    0.00

  7. Volume

    0

  8. Last Traded Quantity

    0

  9. Last Traded Time

    N/A

Price Movement Indicator

0.00

0.00
Today's Low

0.00
Today's High

Concall Report20th Feb 26

Q3 FY26 Earnings Conference Call

BULLISH SENTIMENT

Growth Ratio Summary
Growth Ratio SummaryGrowth Score : 6.00

The company demonstrates strong growth in revenue, operating profit, and assets, but earnings and net income growth are negative. This indicates operational improvements and asset expansion, but profitability is declining. The company needs to address the factors impacting earnings and net income to ensure sustainable growth across all key metrics.

ExcellentRevenue Growth RateExcellent
ExcellentOperating Profit Growth RateExcellent
PoorEarnings Per Share (EPS) GrowthPoor
ExcellentAsset Growth RateExcellent
PoorNet Income Growth RatePoor
Growth RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue Growth Rate11.1425.0919.2344.058.12
Operating Profit Growth Rate13.4610.2225.650.3710.02
Earnings Per Share (EPS) Growth14.22-5.962.56-10.3473.07
Asset Growth Rate24.7153.1997.480.159.22
Net Income Growth Rate14.37-7.886.15-5.5472.8
01.

Revenue Growth Rate

02.

Operating Profit Growth Rate

03.

Earnings Per Share (EPS) Growth

04.

Asset Growth Rate

05.

Net Income Growth Rate

Financial Ratio Summary
Financial Ratio SummaryFinancial Score : 8.00

The company exhibits strong financial performance in earnings per share and book value, but capital expenditures are a concern. High earnings per share and book value reflect enhanced profitability and shareholder value. The company is generating substantial profits for each share and maintaining a strong equity base. However, the company needs to manage its investments more efficiently.

ExcellentAdjusted Earnings Per Share (Adjusted EPS)Excellent
ExcellentCash Earnings Per Share (Cash EPS)Excellent
ExcellentBook Value Per ShareExcellent
GoodDividend Per Share (DPS)Good
PoorCapital Expenditures (CapEx)Poor
Financial RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Adjusted Earnings Per Share (Adjusted EPS)29.1425.8628.528.2949.21
Cash Earnings Per Share (Cash EPS)33.6435.0741.4349.2966.29
Book Value Per Share136.36156.86184.79203.93278.79
Dividend Per Share (DPS)5.987.3107.247.16
Capital Expenditures (CapEx)120841129155297
01.

Adjusted Earnings Per Share (Adjusted EPS)

02.

Cash Earnings Per Share (Cash EPS)

03.

Book Value Per Share

04.

Dividend Per Share (DPS)

05.

Capital Expenditures (CapEx)

Profitability Ratio Summary
Profitability Ratio SummaryProfitability Score : 10.00

The company demonstrates excellent profitability across all key metrics. High margins, returns on capital, equity, and assets indicate efficient and effective management. The company is generating substantial profits from its operations and investments. The company is maximizing shareholder wealth and maintaining a strong competitive position.

ExcellentGross Profit MarginExcellent
ExcellentReturn on Capital Employed (ROCE)Excellent
ExcellentReturn on Equity (ROE)Excellent
ExcellentReturn on Assets (ROA)Excellent
ExcellentOperating MarginExcellent
ExcellentNet MarginExcellent
Profitability RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Gross Profit Margin31.4825.0424.5924.2926.85
Return on Capital Employed (ROCE)2517111214
Return on Equity (ROE)21.2717.0315.3513.1316.6
Return on Assets (ROA)21.9715.8110.0515.0915.2
Operating Margin36.331.9933.735.1835.79
Net Margin30.1422.219.7612.9620.71
01.

Gross Profit Margin

02.

Return on Capital Employed (ROCE)

03.

Return on Equity (ROE)

04.

Return on Assets (ROA)

05.

Operating Margin

06.

Net Margin

Efficiency Ratio Summary
Efficiency Ratio SummaryEfficiency Score : 5.00

The company demonstrates mixed efficiency in utilizing its assets. Inventory management and sales are reasonably well-managed, but fixed asset and capital turnover are low. This suggests potential underutilization of fixed assets and capital. Improving the turnover of fixed assets and overall capital could significantly enhance the company's operational efficiency and profitability.

PoorFixed Asset Turnover RatioPoor
GoodInventory Turnover RatioGood
AverageReceivables Turnover RatioAverage
GoodDays Sales in Inventory RatioGood
WeakReceivable DaysWeak
PoorCapital Turnover RatioPoor
Efficiency RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Fixed Asset Turnover Ratio1.470.660.470.550.6
Inventory Turnover Ratio8.7110.149.478.365.93
Receivables Turnover Ratio8.957.425.626.575.49
Days Sales in Inventory Ratio41.913638.5443.6661.55
Receivable Days40.7849.1964.9555.5666.48
Capital Turnover Ratio0.680.580.610.620.64
01.

Fixed Asset Turnover Ratio

02.

Inventory Turnover Ratio

03.

Receivables Turnover Ratio

04.

Days Sales in Inventory Ratio

05.

Receivable Days

06.

Capital Turnover Ratio

Coverage Ratio Summary
Coverage Ratio SummaryCoverage Score : 8.40

The company's ability to cover its interest expenses is very strong. However, its equity dividend coverage is just average. The company is easily meeting its debt obligations, but its dividend payouts are not as well-covered. The company is able to maintain its debt obligations comfortably.

ExcellentInterest Coverage RatioExcellent
AverageEquity Dividend Coverage RatioAverage
Coverage RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Interest Coverage Ratio111.516.586.073.124.31
Equity Dividend Coverage Ratio53.853.576.25
01.

Interest Coverage Ratio

02.

Equity Dividend Coverage Ratio

Solvency Ratio Summary
Solvency Ratio SummarySolvency Score : 10.00

The company's long-term financial stability is excellent. Low debt levels relative to equity and assets demonstrate a conservative approach to financing, reducing the risk of financial distress. A strong equity base provides a solid foundation for future growth and resilience against economic downturns. The company is well-positioned to manage its long-term obligations and capitalize on growth opportunities without excessive reliance on debt.

ExcellentDebt RatioExcellent
ExcellentDebt to Equity RatioExcellent
ExcellentEquity RatioExcellent
ExcellentDebt To Asset RatioExcellent
Solvency RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debt Ratio0.040.240.210.390.2
Debt to Equity Ratio0.040.320.270.640.25
Equity Ratio0.960.760.790.610.8
Debt To Asset Ratio0.040.20.10.270.14
01.

Debt Ratio

02.

Debt to Equity Ratio

03.

Equity Ratio

04.

Debt To Asset Ratio

Liquidity Ratio Summary
Liquidity Ratio SummaryLiquidity Score : 5.08

The company's ability to meet its short-term obligations is a mix of strengths and weaknesses. While the quick ratio and operating cash flow ratio are at acceptable levels, the current and cash ratios suggest potential difficulties in covering immediate liabilities. This indicates that while the company can convert some assets into cash, its overall liquidity position needs to be stronger to ensure smooth operations and financial flexibility.

WeakCurrent RatioWeak
AverageQuick RatioAverage
WeakCash RatioWeak
AverageOperating Cash Flow RatioAverage
Liquidity RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Current Ratio3.271.50.690.620.79
Quick Ratio2.761.250.640.460.61
Cash Ratio0.220.110.410.110.03
Operating Cash Flow Ratio1.620.560.140.510.22
01.

Current Ratio

02.

Quick Ratio

03.

Cash Ratio

04.

Operating Cash Flow Ratio

Peer Comparison With 17 Companies

Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.

NO Company Name Health Score P/E Ratio Valuation OPM EPS Latest Profit & Loss
1J B Chemicals & Pharmaceuticals Ltd8.1449.64Overvalued1107.0041.98709.00
2Gland Pharma Ltd7.9135.27Overvalued1630.0078.881027.00
3Neuland Laboratories Ltd7.8461.14Highly Overvalued574.00283.01364.00
4Granules India Ltd7.7332.77Highly Overvalued1185.0016.17595.00
5Ajanta Pharma Ltd7.7236.27Neutral1395.0075.781056.00
6Alembic Pharmaceuticals Ltd7.5422.23Undervalued1118.0032.58671.00
7Syngene International Ltd7.4456.08Overvalued918.007.55317.00
8Emcure Pharmaceuticals Ltd7.4036.42Neutral1865.0038.66941.00
9ERIS Lifesciences Ltd7.1532.39Neutral1120.0017.61648.00
10Piramal Pharma Ltd5.83-64.86Neutral922.005.27-326.00
11Jubilant Pharmova Ltd5.7138.62Neutral1260.001.25398.00
12Natco Pharma Ltd5.6911.22Neutral1436.0071.551418.00
13Jeena Sikho Lifecare Ltd5.5231.22Neutral349.0017.87222.00
14Wockhardt Ltd5.07153.40Neutral652.0019.51199.00
15Pfizer Ltd3.4545.16Neutral-82.00157.92300.00
16Procter & Gamble Health Ltd3.4531.71Neutral457.00196.94327.00
17Sanofi India Ltd3.4518.59Neutral491.00134.52413.00
Management Assessment Summary
OrangeBalanced Management

The management of ERIS Lifesciences demonstrates a mixed performance. The company shows strong revenue growth and maintains operational efficiency. However, declining profit growth and increased borrowings raise concerns. Overall, the management's effectiveness is rated as mixed, reflecting strengths in revenue generation and areas for improvement in financial prudence. Recent profit growth concerns and increased debt levels temper an otherwise positive outlook.

Category Metric Value Assessment
PROS Sales Growth [TTM: 44%] strong revenue expansion
Operating Profit Margin [36%] operational efficiency is maintained
CONS Compounded Profit Growth (3Y, TTM) [-5%, -10%] profit growth is declining
Debt/Equity Ratio [2,478 Cr.] leverage is increasing
AverageFinancial Performance & GrowthAverage
AverageCapital Efficiency & ReturnsAverage
WeakFinancial Health & PrudenceWeak
GoodShareholding & Ownership StructureGood
01.

Financial Performance & Growth

02.

Capital Efficiency & Returns

03.

Financial Health & Prudence

04.

Shareholding & Ownership Structure

Risk Assessment Summary
OrangeBalanced Risk

The risk assessment for ERIS Lifesciences indicates a moderate level of risk. The company exhibits strengths in sales growth but faces challenges related to declining profit growth and increased debt. Overall, the risk is assessed as moderate, requiring careful monitoring of key financial metrics.

0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Market Sentiment

Analysis Driven By 26 Technical Indicators From The 1 Hour Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 101440.06Bullish
  3. SMA 201428.99Bullish
  4. SMA 501400.39Bullish
  5. EMA 101439.02Bullish
  6. EMA 201428.37Bullish
  7. EMA 501407.86Bullish
  8. DEMA 101448.41Bearish
  9. DEMA 201447.23Bearish
  10. DEMA 501430.10Bullish
  11. TEMA 101446.92Bearish
  12. TEMA 201451.50Bearish
  13. TEMA 501442.73Bullish
  14. MACD14.03Bullish
  15. ADX42.20Strong Trend
Momentum Indicators (7)
  1. IndicatorValueSignal
  2. RSI61.00Neutral
  3. CCI46.30Neutral
  4. ROC 90.90Bullish
  5. ROC 142.43Bullish
  6. ROC 255.37Bullish
  7. Stoch K64.03Neutral
  8. Stoch D59.18Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper1461.16Neutral
  3. BB Middle1428.99Neutral
  4. BB Lower1396.83Neutral
  5. ATR17.80High Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI54.46Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Market Sentiment

Analysis Driven By 26 Technical Indicators From The 2 Hours Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 101433.14Bullish
  3. SMA 201409.41Bullish
  4. SMA 501388.21Bullish
  5. EMA 101432.33Bullish
  6. EMA 201417.09Bullish
  7. EMA 501396.70Bullish
  8. DEMA 101449.53Bearish
  9. DEMA 201439.53Bullish
  10. DEMA 501415.93Bullish
  11. TEMA 101452.55Bearish
  12. TEMA 201449.75Bearish
  13. TEMA 501428.82Bullish
  14. MACD17.76Bullish
  15. ADX44.30Strong Trend
Momentum Indicators (7)
  1. IndicatorValueSignal
  2. RSI67.78Neutral
  3. CCI84.24Neutral
  4. ROC 92.42Bullish
  5. ROC 145.07Bullish
  6. ROC 255.71Bullish
  7. Stoch K78.68Neutral
  8. Stoch D78.01Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper1463.00Neutral
  3. BB Middle1409.41Neutral
  4. BB Lower1355.82Neutral
  5. ATR20.76High Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI65.33Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Market Sentiment

Analysis Driven By 26 Technical Indicators From The 4 Hours Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Strong Bullish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 101408.67Bullish
  3. SMA 201392.13Bullish
  4. SMA 501379.29Bullish
  5. EMA 101416.06Bullish
  6. EMA 201400.87Bullish
  7. EMA 501383.71Bullish
  8. DEMA 101436.28Bullish
  9. DEMA 201420.34Bullish
  10. DEMA 501401.41Bullish
  11. TEMA 101444.80Bullish
  12. TEMA 201432.24Bullish
  13. TEMA 50N/AN/A
  14. MACD16.24Bullish
  15. ADX18.47Weak Trend
Momentum Indicators (7)
  1. IndicatorValueSignal
  2. RSI66.71Neutral
  3. CCI143.06Overbought
  4. ROC 94.02Bullish
  5. ROC 145.86Bullish
  6. ROC 253.03Bullish
  7. Stoch K83.07Overbought
  8. Stoch D87.04Overbought
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper1444.52Overbought
  3. BB Middle1392.12Neutral
  4. BB Lower1339.73Neutral
  5. ATR28.71High Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI60.15Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Market Sentiment

Analysis Driven By 33 Technical Indicators From The 1 Day Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Strong Bullish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (22)
  1. IndicatorValueSignal
  2. SMA 101392.69Bullish
  3. SMA 201380.28Bullish
  4. SMA 501377.66Bullish
  5. SMA 1001368.97Bullish
  6. SMA 2001483.38Bearish
  7. EMA 101402.26Bullish
  8. EMA 201388.88Bullish
  9. EMA 501378.89Bullish
  10. EMA 1001398.28Bullish
  11. EMA 2001436.17Bullish
  12. DEMA 101421.91Bullish
  13. DEMA 201404.94Bullish
  14. DEMA 501376.25Bullish
  15. DEMA 1001344.45Bullish
  16. DEMA 2001407.31Bullish
  17. TEMA 101433.56Bullish
  18. TEMA 201415.42Bullish
  19. TEMA 501401.83Bullish
  20. TEMA 1001347.39Bullish
  21. TEMA 2001315.13Bullish
  22. MACD13.74Bullish
  23. ADX16.50Weak Trend
Momentum Indicators (6)
  1. IndicatorValueSignal
  2. RSI61.76Neutral
  3. CCI232.80Overbought
  4. ROC 145.08Bullish
  5. ROC 255.42Bullish
  6. Stoch K90.44Overbought
  7. Stoch D80.37Overbought
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper1433.28Overbought
  3. BB Middle1380.27Neutral
  4. BB Lower1327.27Neutral
  5. ATR44.78High Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI53.65Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Market Sentiment

Analysis Driven By 21 Technical Indicators From The 1 Week Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (10)
  1. IndicatorValueSignal
  2. SMA 201367.70Bullish
  3. SMA 501524.33Bearish
  4. EMA 201395.08Bullish
  5. EMA 501437.54Bearish
  6. DEMA 201346.12Bullish
  7. DEMA 501441.62Bearish
  8. TEMA 201352.26Bullish
  9. TEMA 501340.62Bullish
  10. MACD-31.69Bullish
  11. ADX11.31Weak Trend
Momentum Indicators (6)
  1. IndicatorValueSignal
  2. RSI48.18Neutral
  3. CCI-68.76Neutral
  4. ROC 143.23Bullish
  5. ROC 25-10.63Bearish
  6. Stoch K57.45Neutral
  7. Stoch D53.57Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper1444.72Neutral
  3. BB Middle1367.70Neutral
  4. BB Lower1290.68Neutral
  5. ATR104.39Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI60.75Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Market Sentiment

Analysis Driven By 25 Technical Indicators From The 1 Month Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 61376.42Bullish
  3. SMA 121526.20Bearish
  4. SMA 241423.78Bearish
  5. EMA 61396.26Bullish
  6. EMA 121426.54Bearish
  7. EMA 241358.39Bullish
  8. DEMA 61342.47Bullish
  9. DEMA 121432.89Bearish
  10. DEMA 241543.13Bearish
  11. TEMA 61328.02Bullish
  12. TEMA 121340.96Bullish
  13. TEMA 241515.14Bearish
  14. MACD213.80Bearish
  15. ADX38.29Strong Trend
Momentum Indicators (6)
  1. IndicatorValueSignal
  2. RSI57.58Neutral
  3. CCI67.38Neutral
  4. ROC 2556.15Bullish
  5. ROC 50103.14Bullish
  6. Stoch K64.94Neutral
  7. Stoch D76.85Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper1803.79Neutral
  3. BB Middle1464.68Neutral
  4. BB Lower1125.56Neutral
  5. ATR222.99Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI54.98Neutral